•Experts suggest primary objectives for national HEV surveillance in EU/EEA countries.•to monitor the incidence of acute HEV cases.•to monitor chronic HEV infections.•to describe the epidemiology of acute and chronic HEV infections.•Suggested secondary objectives for national HEV surveillance in EU/EEA countries:•to monitor HEV phylotypes/subtypes.•to identify potential clusters/outbreaks.•to collect information on possible routes of transmission.•Overall, the majority of EU/EEA countries collect the suggested data and meet the outlined requirements to confirm an acute case. Hepatitis E virus (HEV) infection is not notifiable at EU/EEA level, therefore surveillance relies on national policies only. Between 2005 and 2015, more than 20,000 cases were reported in EU/EEA countries. HEV testing is established in 26 countries and 19 countries sequence HEV viruses. WHO's European Action plan for viral hepatitis recommends harmonised surveillance objectives and case definitions. ECDC's HEV expert group developed minimal and optimal criteria for national hepatitis E surveillance to support EU/EEA countries in enhancing their capacity and to harmonise methods. The experts agreed that the primary objectives of national surveillance for HEV infections should focus on the basic epidemiology of the disease: to monitor the incidence of acute cases and chronic infections. The secondary objectives should be to describe viral phylotypes or subtypes and to identify potential clusters/outbreaks and possible routes of transmission. Seventeen of 20 countries with existing surveillance systems collect the minimal data set required to describe the epidemiology of acute cases. Eleven countries test for chronic infections. Twelve countries collect data to identify potential clusters/outbreaks and information on possible routes of transmission. Overall, the majority of EU/EEA countries collect the suggested data and meet the outlined requirements to confirm an acute case.